Bantam Pharmaceutical Accelerates BTM-3566 Clinical Program Expanding Phase 1 Trial into Canada
RESEARCH TRIANGLE PARK, N.C., March 6, 2025 /PRNewswire/ -- Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, today announced it is proceeding